Agape ATP Corporation

NasdaqCM:ATPC

Location

Market Cap

USD 78.51 M

Share Price

USD 1.57

Avg Daily Volume

826,376

Change (1 day)

2.61%

Change (1 year)

Change (YTD)

69.73%

Agape ATP Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.29 M

Agape ATP Corporation Revenue is USD 1.29 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.54% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Agape ATP Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.37 M, a -25.13% change year over year.
  • Agape ATP Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.83 M, a 62.65% change year over year.
  • Agape ATP Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.12 M, a -70.06% change year over year.
  • Agape ATP Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 3.75 M, a 253.33% change year over year.
Key data
Date Revenue Revenue Gross Profit Operating Income
Market news
Loading...
NasdaqCM: ATPC

Agape ATP Corporation

CEO Dr. Kok Choong How
IPO Date Sept. 11, 2023
Location Malaysia
Headquarters Lot 1705 – 1708, Faber Towers
Employees 16
Sector 🏥 Health Care
Industries
Description

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Similar companies

LLY

Eli Lilly and Company

USD 762.73

-2.84%

JNJ

Johnson & Johnson

USD 149.79

-0.62%

NOVO-B.CO

Novo Nordisk A/S

USD 73.32

-2.33%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

ABT

Abbott Laboratories

USD 132.99

0.44%

NOVN.SW

Novartis AG

USD 115.96

-0.50%

AZN.L

AstraZeneca PLC

USD 140.24

-1.30%

MRK

Merck & Co., Inc.

USD 79.06

-0.29%

AMGN

Amgen Inc.

USD 289.33

-0.10%

PFE

Pfizer Inc.

USD 23.97

0.38%

GILD

Gilead Sciences, Inc.

USD 108.50

0.46%

SAN.PA

Sanofi

USD 95.88

0.36%

VRTX

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

BMY

Bristol-Myers Squibb Company

USD 46.86

0.04%

MCK

McKesson Corporation

USD 720.92

-1.10%

ELV

Elevance Health Inc.

USD 374.52

-0.37%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK.L

GSK plc

USD 18.89

-2.25%

CSL.AX

CSL Limited

USD 154.82

0.08%

ZTS

Zoetis Inc.

USD 157.17

1.36%

COR

Cencora, Inc.

USD 293.66

-1.04%

REGN

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

LONN.SW

Lonza Group AG

USD 684.56

0.23%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

RKT.L

Reckitt Benckiser Group plc

USD 68.48

-0.44%

HLN.L

Haleon plc

USD 5.16

0.21%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

USD 19.22

1.16%

4568.T

Daiichi Sankyo Company, Limited

USD 22.63

-2.53%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB.BR

UCB SA

USD 181.46

0.14%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

RGC

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

BAYN.DE

Bayer AG

USD 30.75

-0.65%

068270.KS

Celltrion, Inc.

USD 117.76

1.81%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.39

0.82%

4578.T

Otsuka Holdings Co., Ltd.

USD 47.94

-0.46%

SDZ.SW

Sandoz Group AG

USD 53.32

-0.10%

LH

Laboratory Corporation of America Holdings

USD 261.88

0.19%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.57

0.90%

DIVISLAB.NS

Divi's Laboratories Limited

USD 76.09

1.62%

TEVA.TA

Teva Pharmaceutical Industries Limited

USD 17.30

1.37%

RPRX

Royalty Pharma plc

USD 34.86

-0.14%

INSM

Insmed Incorporated

USD 102.68

3.24%

BIIB

Biogen Inc.

USD 127.04

0.40%

600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.92

0.34%

4503.T

Astellas Pharma Inc.

USD 9.25

-0.70%

StockViz Staff

June 22, 2025

Any question? Send us an email